12:00 AM
Feb 13, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

AC165198: Phase I started

Amylin disclosed in its 4Q11 earnings that in January it began a Phase I trial to evaluate AC165198. Amylin and...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >